News

Filter

Current filters:

Intron A

1 to 9 of 143 results

Drug Royalty buys 25% of Peg-Intron royalties

03-09-2007

Canadian privately-held investment company Drug Royalty has purchased 25% of US drugmaker Enzon Pharmaceuticals'…

AlphaInterferon alfa-2bIntron APeg-IntronPeginterferon alfa-2bProlastinRecombinant for InjectionSchering PloughSchering-Plough

S-P subsidiary fined $435.0M

29-01-2007

Schering Sales Corp, a subsidiary of US drug major Schering-Plough, has been sentenced to pay $435.0…

ClaritinInterferon alfa-2bIntron ALoratadineRecombinant for InjectionSchering PloughSchering-PloughTemodarTemozolomide

S-P granted EU label change for Intron A

01-05-2006

US drugmaker Schering-Plough says that the European Commission has adopted changes to the European Union…

CopegusInterferon alfa-2bIntron ARebetolRecombinant for InjectionRibavirinSchering PloughSchering-PloughVirazole

1 to 9 of 143 results

COMPANY SPOTLIGHT

Menarini

Back to top